Clinical Evidence

Explore the clinical evidence shaping the probiotics market today

Filter by Wellness Area

Therapeutical Areas to Clinical Evidence (desktop)
  • All
  • Weight Management
  • Gastrointestinal health
  • Pediatric health
  • Oral health
  • Cardiometabolic health
  • Immune health
  • Cognitive health
  • Skin health
  • Women's health
Therapeutical Areas to Clinical Evidence (mobile)

Filter by Product

Products to Clinical Evidence (desktop)
  • All
  • LipiGO®
  • KABP® CysCare
  • KABP® DENTISANI
  • KABP® DENTALAC
  • KABP® Gyntima Vaginal Restore
  • KABP® Digest
  • KABP®-051
  • KABP® DR7
  • Lactobacillus <i>plantarum</i> DR7®
  • KABP® Kolicare
  • KABP® AB21®
  • KABP® Metaguard
  • KABP® L. sakei
  • KABP® Menopause
  • KABP® Intensive G.I.
  • KABP® Innerim
Products to Clinical Evidence (mobile)
  • Novel Application of Oral Postbiotics for Skin Condition in Healthy Middle-Aged Women: A Randomized, Double-Blind, and Placebo-Controlled Study

    2025

    Sawashita et al

    Read
  • Efficacy and safety of Latilactobacillus sakei LB-P12 in patients with knee osteoarthritis: an exploratory randomized, double-blind, placebo-controlled clinical trial

    2025

    Shine, B. K. et al. E

    Read
  • Latilactobacillus sakei LB-P12 Ameliorates Osteoarthritis by Reducing Cartilage Degradation and Inflammation via Regulation of NF-κB/HIF-2α Pathway

    2025

    Song, M., Kim, W. J., Shim, J. & Song, K

    Read
  • Immune-modulating characteristics of Lactobacillus sakei proBio65 isolated from Kimchi

    2011

    Lim J, et al

    Read